The design of combination hormonal and immunotherapeutic protocols for breast cancer patients may be facilitated by analysis of preclinical in vitro model systems .
the design of combination hormonal and immunotherapeutic protocols for breast cancer patients may be facilitated by analysis of preclinical in vitro model systems .
O O O O O O B-other_name I-other_name O B-multi_cell I-multi_cell B-multi_cell O O O O O O O O B-other_name I-other_name I-other_name O